Use of colloids of chromic [32P] phosphate in treatment of solid tumors
MB Zubillaga, JR Boccio, JO Nicolini, R Ughetti… - Nuclear medicine and …, 1996 - Elsevier
In order to evaluate the effectiveness of an intratumorally single dose of chromic [32P]
phosphate for the treatment of solid tumors, studies of bioelimination, biodistribution, and …
phosphate for the treatment of solid tumors, studies of bioelimination, biodistribution, and …
Radiochemical and radiopharmacological properties of Pirocarbotrat and other labeled charcoal dispersions: comparative studies in rats with NMU-induced mammary …
MB Zubillaga, JR Boccio, JO Nicolini, R Ughetti… - Nuclear medicine and …, 1998 - Elsevier
The purpose of this work is to study the physicochemical properties of Pirocarbotrat to
explain its radiopharmacological behavior. We also studied a mixture of charcoal plus …
explain its radiopharmacological behavior. We also studied a mixture of charcoal plus …
[PDF][PDF] Pirocarbotrat–a new radiopharmaceutical labeled with 32P for the treatment of solid tumours, therapeutic action and radiodosimetric calculations in therapeutic …
M Zubillaga, J Boccio, G Calmanovivi… - Therapeutic applications …, 2001 - Citeseer
Pirocarbotrat™ is a gelatin protected charcoal suspension labelled with chromic [32P]
pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the treatment of solid …
pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the treatment of solid …
放射性^(32) P-磷酸铬胶体治疗 H22 移植瘤的实验研究
童冠圣， 黄培林， 刘璐， 张丽达， 黄鹰 - 东南大学学报: 医学版, 2003 - cqvip.com
目的: 探讨不同剂量的32P-磷酸铬(Cr32PO4) 胶体局部注射对小鼠H22 移植瘤和区域淋巴结
转移灶的治疗作用. 方法: 建立小鼠H22 移植瘤模型14 d 后分别给予高, 中, 低剂量的Cr32PO4 …
转移灶的治疗作用. 方法: 建立小鼠H22 移植瘤模型14 d 后分别给予高, 中, 低剂量的Cr32PO4 …
Pirocarbotrate {sup TM}: A new radiopharamaceutical labelled with {sup 32} P for the treatment of solid tumours. Therapeutic action and radiodosimetric calculations
M Zubillaga, J Boccio, G Calmanovici, C Goldman… - 2001 - osti.gov
Pirocarbotrat {sup TM} is a gelatin protected charcoal suspension labelled with chromic
[{sup 32} P] pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the …
[{sup 32} P] pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the …
PirocarbotrateTM: A new radiopharamaceutical labelled with 32P for the treatment of solid tumours. Therapeutic action and radiodosimetric calculations
M Zubillaga, J Boccio, G Calmanovici, C Goldman… - 2001 - inis.iaea.org
Pirocarbotrat™ is a gelatin protected charcoal suspension labelled with chromic [32P]
pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the treatment of solid …
pyrophosphate. To evaluate its effectiveness as a therapeutic agent for the treatment of solid …
Improvement of Radioactive Colloid Binding by Tumor Cells
LJ Anghileri, C Marchal, P Maincent… - Tumori …, 1990 - journals.sagepub.com
Treatment of P388 leukemia cells with poly-DL-lysine (Poly-lys) considerably increases the
binding of colloidal chromic phosphate (32P). This augmentation of the number of particles …
binding of colloidal chromic phosphate (32P). This augmentation of the number of particles …
[HTML][HTML] Design and characterization of a {sup 32} P-patch for the treatment of skin diseases. Studies of its application as a betatherapeutic agent for modulated …
MJ Salgueiro - 2010 - osti.gov
The purpose of this work was to design and evaluate a {sup 32} P-patch for contact
brachytherapy of skin diseases.[{sup 32} P]-chromic phosphate in combination with silicone …
brachytherapy of skin diseases.[{sup 32} P]-chromic phosphate in combination with silicone …
[CITATION][C] Introduction to radiocolloids
RH Seevers - Spencer RP, Seevers RH, Friedman A, 1987